Can experimental activation of telomerase influence the antiviral function of human immune cells? A laboratory study published in the Journal of Immunology in 2008 explored this question.
The study focused on human CD8⁺ T lymphocytes, which play a crucial role in defending against virus-infected cells. Researchers investigated the experimental telomerase activator TAT2.
Important: The study was conducted using TAT2 and did not examine the dietary supplement TA-65®. Therefore, the laboratory results must not be interpreted as clinical proof of efficacy for TA-65®.
Further information on the biological fundamentals can be found in our expert article: Telomeres and Telomerase.
What role do CD8⁺ T cells play in immune defense?
CD8⁺ T lymphocytes are part of the adaptive immune system. They can recognize virus-infected body cells and, under certain conditions, target them for destruction.
Furthermore, they produce various signaling molecules, known as cytokines and chemokines, which are involved in the immune response.
In chronic infections such as HIV-1, changes can occur in specific CD8⁺ T cell populations. These include limited proliferative capacity, alterations in cell function, and shortened telomeres.
Consequently, telomerase is a subject of research when it comes to the long-term function and replicative capacity of such immune cells.
What was examined in the study?
The researchers examined human immune cells from blood samples of healthy individuals and those infected with HIV-1.
A primary focus was on CD8⁺ T cells from individuals with an HIV-1 infection. The cells were treated in the laboratory with the experimental telomerase activator TAT2.
Specifically, the researchers examined:
- The activity of the enzyme telomerase.
- Changes in telomere length.
- The proliferative and replicative capacity of the immune cells.
- The production of specific cytokines and chemokines.
- Antiviral activity against HIV-1 in experimental cell culture models.
The investigations were conducted in vitro, i.e., on cells outside the human body.
This was not a clinical treatment study on patients.
What results were observed?
Treatment with TAT2 led to increased telomerase activity in the examined immune cells.
In longer-term cell culture experiments, a moderate slowing of telomere shortening was also observed.
Under the experimental conditions, the treated CD8⁺ T cells showed a greater potential for cell proliferation.
These findings suggest that experimental alteration of telomerase activity can influence certain cellular processes.
How did TAT2 influence antiviral function?
The researchers also examined how CD8⁺ T cells responded to HIV-1-specific stimuli.
Under treatment with TAT2, an increased production of certain immune signaling molecules was observed in the studied cell cultures.
These included, among others, interferon-gamma as well as the chemokines MIP-1α, MIP-1β, and RANTES.
In experimental cell culture models, the treated CD8⁺ T cells were able to suppress HIV-1 replication more effectively than the corresponding control cells.
When telomerase was blocked with a specific inhibitor, these effects largely diminished.
This suggests that the observed changes were essentially linked to telomerase activity.
The results relate exclusively to the laboratory conditions examined. They do not prove that TAT2 or TA-65® can treat or prevent an HIV infection in humans.
Why is telomerase of interest in immune research?
Telomerase can add specific DNA repeat sequences to chromosome ends and thereby contribute to the maintenance of telomeres.
When immune cells are activated, their natural telomerase activity can also increase.
Since the proliferative capacity of immune cells plays an important role in long-lasting immune responses, research is being conducted into the influence of telomere maintenance on certain immune cell functions.
However, higher telomerase activity is not fundamentally synonymous with a health benefit.
Telomerase also plays an important role in many cancer cells. Therefore, interventions in its regulation must be carefully studied from a scientific perspective.
How should the results be classified scientifically?
The publication provides experimental evidence that pharmacological activation of telomerase can influence certain properties of human CD8⁺ T cells.
The most important limitations are:
- The studies took place primarily in cell cultures.
- The experimental agent TAT2 was used.
- No clinical treatment successes in HIV patients were investigated.
- The results do not allow for reliable conclusions regarding long-term safety or health effects in humans.
- The findings cannot be easily applied to other products or dietary supplements.
Some authors were affiliated with a company involved in telomerase research at the time of publication. This potential conflict of interest should be taken into account when evaluating the study.
Frequently asked questions about telomerase and CD8⁺ T cells
What are CD8⁺ T cells?
CD8⁺ T cells are immune cells of the adaptive immune system. They play an important role, in particular, in recognizing and combating virus-infected cells.
Can telomerase influence the proliferative capacity of immune cells?
Telomerase can contribute to the maintenance of telomeres. In experimental studies, it has been observed that altered telomerase activity can be associated with changes in the proliferative capacity of certain immune cells.
What is TAT2?
TAT2 is the name for an experimentally studied telomerase activator. Its effect on human immune cells under laboratory conditions was investigated in the described study.
Was TA-65® examined in this study?
No. The publication examined the experimental activator TAT2 and not the finished dietary supplement TA-65®. The observed laboratory results are therefore not independent proof of efficacy for TA-65®.
Does the study prove improved immune defense in humans?
No. The results were obtained under controlled laboratory conditions. It cannot be deduced whether comparable changes occur during treatment in humans.
Conclusion: Telomerase activation and antiviral immune function
The study from 2008 shows that experimental activation of telomerase can influence certain properties of human CD8⁺ T cells in the laboratory.
Under treatment with TAT2, increased telomerase activity, a moderate slowing of telomere shortening, and changes in certain immune functions were observed.
These findings are of interest for fundamental research into immune aging and telomere biology.
However, they do not allow for the assertion that TA-65® improves immune defense or treats viral diseases in humans.
Original scientific publication
Fauce, S. R. et al. (2008): Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes. The Journal of Immunology, 181(10), 7400–7406.
Read the original publication on PubMed →
